The Gen-Probe Group A Streptococcus Direct Test (GP-ST) is a new assay which utilizes a nucleic acid probe to detect group A streptococci directly from pharyngeal swabs. In this study, 1,103 specimens were cultured and tested by GP-ST. The sensitivities and specificities were as follows: culture, 98.8 and 100lo; GP-ST, 92 Some of the pledgets (rayon plugs) in the Culturette holders were cultured in broth to resolve discrepant results. This was done by carefully cutting the Culturette holder with a pair of scissors just above the pledget. The pledget was removed with sterile forceps and placed in a 5-ml tube of Todd-Hewitt broth. Following overnight incubation at 350C, the Todd-Hewitt broth was subcultured to SSA and tryptic soy agar with 5% sheep blood and examined in the same manner as routine cultures.
Laboratory diagnosis of group A streptococcal pharyngitis in the United States is made primarily by culture or rapid streptococcal antigen detection methods. Recently, a commercially manufactured kit was developed which permits detection of group A streptococci (GAS) directly in pharyngeal specimens with a nucleic acid probe. The kit is manufactured by Gen-Probe Inc. (San Diego, Calif.) and is named the Group A Streptococcus Direct Test (GP-ST).
The purpose of this study was to examine the performance characteristics of the GP-ST in comparison with those of culture and a rapid streptococcal antigen test for the diagnosis of GAS.
(This study was presented in part at the 93rd General Meeting of the American Society for Microbiology, Atlanta, Ga., [16] [17] [18] [19] [20] May 1993.)
MATERIALS AND METHODS
In our institution, Culturette brand swabs (Becton Dickinson Microbiology Systems, Cockeysville, Md.) are utilized for collection of specimens for culture of GAS. If a direct streptococcal antigen test is also ordered, a Culturette II is used to collect the specimen.
All specimens were collected from emergency room or pediatric or adult clinic patients at the Geisinger Medical Center. When two swabs we;11-collected, one was used for culture and the GP-ST. The Some of the pledgets (rayon plugs) in the Culturette holders were cultured in broth to resolve discrepant results. This was done by carefully cutting the Culturette holder with a pair of scissors just above the pledget. The pledget was removed with sterile forceps and placed in a 5-ml tube of Todd-Hewitt broth. Following overnight incubation at 350C, the Todd-Hewitt broth was subcultured to SSA and tryptic soy agar with 5% sheep blood and examined in the same manner as routine cultures.
To remove any unintentional bias in the study, the GP-ST 
RESULTS
Specimens from 1,103 patients were cultured and tested with the GP-ST. Of these specimens, 808 were also tested with the TP-ST.
When each day of testing was completed, the results were compared. If the culture and GP-ST results did not agree, two steps were taken. First, the SSA plate was carefully reexamined by a senior technologist. Second, the GP-ST was repeated with the reserved lysate. For specimens which remained disparate, the pledgets from the Culturette holders were cultured in Todd-Hewitt broth and worked up as previously described.
Of the 1,103 specimens tested, 836 were negative and 241 were positive by both culture and the GP-ST. Twenty were positive by culture only and were classified as falsely negative by GP-ST. Three isolates were GP-ST positive, positive for GAS from pledget culture, and SSA culture negative; these three were classified as false-negative culture results. Table 1 summarizes the performance characteristics of culture and the GP-ST. (2, 5, 9) .
Commercially available nucleic acid probe assays for GAS are a recent development. Limited investigations have been performed with nucleic acid probes for detection of GAS from specimens enriched for 4 to 12 h in broth cultures (4, 8) . An even more recent development is a commercial kit for performance of tests for GAS directly with pharyngeal swabs. The purpose of this study was to evaluate this kit, the GP-ST, in comparison with culture and a streptococcal antigen test.
The performance characteristics of the GP-ST in the study were excellent, particularly in comparison with those of the TP-ST. For specimens in the study that were tested by all three methods, the sensitivities for GP-ST, TP-ST, and culture were 93. 5 In comparison with our experience with other Gen-Probe assays, we found the GP-ST easier to perform. This is most noticeable when the GP-ST is compared with assays with radioactive labels, such as the Mycoplasma pneumoniae assay. The GP-ST is also simpler to perform that the Pace 2 assay for Chlamydia trachomatis.
We have previously conducted two studies, evaluating broth enrichment techniques designed to facilitate same-day reporting of specimens collected in the morning or afternoon (1, 3) . The sensitivity of the GP-ST in this study is comparable to those of the broth enrichment methods which we have previously evaluated.
The ideal use of the GP-ST may be as a definitive replacement for testing of specimens for which both a direct streptococcal antigen assay and culture are ordered. Speculation on the cost effectiveness of this approach is complicated because the cost of the GP-ST has not been established. If On the basis of our data, if the cutoff for a positive test result were lowered from 4,500 to 3,500 RLU, the sensitivity of the GP-ST would increase from 92.4 to 94.3%; however, the specificity would drop from 99.6 to 96.3%. There would also be a decrease in the predictive value of a positive test result from 98.8 to 88.4%, a decrease that we deem unacceptable. The data from this study support the cutoff value of 4,500 RLU.
Another approach to improving sensitivity would be to establish an indeterminate range and culture the pledgets from specimens falling in that range. In this study, there were 35 specimens (3.2% of all specimens) with values between 3,500 and 4,499 RLU. Six of these 35 specimens were culture positive on SSA as well as pledget culture positive. On the basis of the data from this study, culturing of the pledgets from all specimens with values of 3,500 to 4,499 RLU would require 30 to 35 cultures per 1,000 tests. We believe that this selective culture technique is merited if the increased sensitivity demonstrated in this study (92.4% without the indeterminate zone; 94.7% with the indeterminate zone) can be substantiated by further studies. If this protocol were followed, approximately 99% of all test results would remain unchanged by culture of the pledget. In this study, pledgets were cultured in Todd-Hewitt broth overnight before subculture to SSA and tryptic soy agar with 5% sheep blood. However, our experience with enrichment broths for GAS in previous studies leads us to believe that a shorter incubation period may be adequate (1, 3) .
The performance characteristics of comparative test methodologies for detection of GAS are influenced by a variety of characteristics, including patient age, population selection, the prevalence of GAS in the population at the time of the study, and perhaps most importantly, the culture technique (6) . Therefore, caution should be exercised in assessing the performance characteristics of a new assay, such as the GP-ST, on the basis of a study in one laboratory.
In two previous studies performed in our laboratory, the sensitivities of the TP-ST in comparison with culture on SSA were 72.6 and 70.4%. The prevalences of positive test results for these same two studies were 22 and 23%, respectively. In this latest study, the sensitivity of the TP-ST was 76% in comparison with culture on SSA while the prevalence of GAS was 26.6%. We do not know whether the variables which produced a higher sensitivity than previously observed in our laboratory for the TP-ST also positively influenced the GP-ST.
Additional studies of the GP-ST are needed to evaluate its clinical performance more fully. Evaluations of different patient populations, in particular those with lower prevalences of GAS-positive cultures, are needed.
